Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.

de Vries JI, van Pampus MG, Hague WM, Bezemer PD, Joosten JH; FRUIT Investigators.

J Thromb Haemost. 2012 Jan;10(1):64-72. doi: 10.1111/j.1538-7836.2011.04553.x. Erratum in: J Thromb Haemost. 2015 Feb;13(2):327.

2.

Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.

van Hoorn ME, Hague WM, van Pampus MG, Bezemer D, de Vries JI; FRUIT Investigators.

Eur J Obstet Gynecol Reprod Biol. 2016 Feb;197:168-73. doi: 10.1016/j.ejogrb.2015.12.011. Epub 2015 Dec 19.

PMID:
26771908
3.

Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT: a rebuttal.

Bujold E, Gouin K, Côté S.

J Thromb Haemost. 2012 Jun;10(6):1195; author reply 1196. doi: 10.1111/j.1538-7836.2012.04688.x. No abstract available.

4.

Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.

Roberge S, Demers S, Nicolaides KH, Bureau M, Côté S, Bujold E.

Ultrasound Obstet Gynecol. 2016 May;47(5):548-53. doi: 10.1002/uog.15789. Epub 2016 Apr 3. Review.

5.

Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.

Areia AL, Fonseca E, Areia M, Moura P.

Arch Gynecol Obstet. 2016 Jan;293(1):81-6. doi: 10.1007/s00404-015-3782-2. Epub 2015 Jun 10.

PMID:
26059084
6.

[Thrombophilia, preeclampsia and other pregnancy complications].

Vucić N, Frleta M, Petrović D, Ostojić V.

Acta Med Croatica. 2009 Oct;63(4):297-305. Review. Croatian.

PMID:
20034330
7.

Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.

de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S.

Cochrane Database Syst Rev. 2014 Jul 4;(7):CD004734. doi: 10.1002/14651858.CD004734.pub4. Review.

PMID:
24995856
8.

Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.

Rodger MA, Gris JC, de Vries JIP, Martinelli I, Rey É, Schleussner E, Middeldorp S, Kaaja R, Langlois NJ, Ramsay T, Mallick R, Bates SM, Abheiden CNH, Perna A, Petroff D, de Jong P, van Hoorn ME, Bezemer PD, Mayhew AD; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group.

Lancet. 2016 Nov 26;388(10060):2629-2641. doi: 10.1016/S0140-6736(16)31139-4. Epub 2016 Oct 6.

PMID:
27720497
9.

Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.

Riyazi N, Leeda M, de Vries JI, Huijgens PC, van Geijn HP, Dekker GA.

Eur J Obstet Gynecol Reprod Biol. 1998 Sep;80(1):49-54.

PMID:
9758259
10.

Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?

Kalk JJ, Huisjes AJ, de Groot CJ, van Beek E, van Pampus MG, Spaanderman ME, van Eyck J, Oei SG, Bezemer PD, de Vries JI.

Neth J Med. 2004 Mar;62(3):83-7.

11.
12.

Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.

Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J, Gent M.

J Rheumatol. 2009 Feb;36(2):279-87. doi: 10.3899/jrheum.080763).

PMID:
19208560
13.

Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy.

Abheiden CNH, Fuijkschot WW, Arduç A, van Diemen JJK, Harmsze AM, de Boer MA, Thijs A, de Vries JIP.

Eur J Obstet Gynecol Reprod Biol. 2017 Mar;210:139-143. doi: 10.1016/j.ejogrb.2016.12.023. Epub 2016 Dec 21.

PMID:
28033561
14.

ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.

de Jong PG, Quenby S, Bloemenkamp KW, Braams-Lisman BA, de Bruin JP, Coomarasamy A, David M, DeSancho MT, van der Heijden OW, Hoek A, Hutten BA, Jochmans K, Koks CA, Kuchenbecker WK, Mol BW, Torrance HL, Scheepers HC, Stephenson MD, Verhoeve HR, Visser J, de Vries JI, Goddijn M, Middeldorp S.

Trials. 2015 May 7;16:208. doi: 10.1186/s13063-015-0719-9.

15.

Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.

Mutlu I, Mutlu MF, Biri A, Bulut B, Erdem M, Erdem A.

Blood Coagul Fibrinolysis. 2015 Apr;26(3):267-73. doi: 10.1097/MBC.0000000000000219.

PMID:
25268607
16.

Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.

Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004734. doi: 10.1002/14651858.CD004734.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD004734.

PMID:
19160241
17.

Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications.

Bar J, Mashiah R, Cohen-Sacher B, Hod M, Orvieto R, Ben-Rafael Z, Lahav J.

Thromb Res. 2001 Feb 15;101(4):235-41.

PMID:
11248284
18.

Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.

Brenner B, Hoffman R, Blumenfeld Z, Weiner Z, Younis JS.

Thromb Haemost. 2000 May;83(5):693-7.

PMID:
10823264
19.

Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.

Groom KM, McCowan LM, Stone PR, Chamley LC, McLintock C; EPPI trial Study Group.

BMC Pregnancy Childbirth. 2016 Nov 22;16(1):367.

20.

Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication.

Spaanderman ME, Aardenburg R, Ekhart TH, van Eyndhoven HW, de Leeuw PW, Peeters LL.

J Soc Gynecol Investig. 2005 Feb;12(2):112-7.

PMID:
15695106

Supplemental Content

Support Center